PRODUCT LITERATURE

Remdesivir in COVID-19: A critical review of pharmacology, preclinical and clinical studies

---

Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 infection (COVID-19), remdesivir has been tried for a compassionate use in severe COVID-19. Newer randomized controlled studies that have recently become available, showed a mixed result. We aimed to systematically search the literature to understand the pharmacology and clinical effects of remdesivir in patients with COVID19.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Jubi-R

Specific Detail Info

/ Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (2020) 641e648

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment